PARTNERSHIPS
Scientific Partnerships Across Pharmaceutical Development
Complex solid-state questions often sit at the interface of discovery, API development, manufacturing and formulation. TeraCrystal works as a specialist scientific contributor within this wider ecosystem. We aim to define each collaboration around the development question, the required expertise and a clear division of responsibilities.
Who we work with
For CMC, API development, solid-state chemistry and analytical development teams, we contribute focused investigations to support solid-form selection, phase identification, crystallization understanding and related development decisions.
For teams building a development strategy with limited in-house specialist resources, we help identify solid-state uncertainties early and design targeted investigations that can inform subsequent decisions.
We can complement existing development and manufacturing expertise through specialist support in polymorphism, crystallization questions and structural investigation. Project responsibilities and any transfer of results are agreed with the manufacturing partner.
We address selected API solid-form, particle-attribute, physical-stability and dissolution-related questions that may be relevant to the interface between API properties and oral dosage-form development.
Where relevant to the formulation, we can investigate API crystallization or recrystallization, phase stability and solid-state changes associated with creams, gels or ointments during processing or storage.
We welcome appropriately scoped collaborations involving complementary methods, research questions, specialist referrals and integrated scientific projects, with authorship, confidentiality and intellectual-property arrangements defined in advance.
For pharmaceutical and biotech teams seeking broader development support, TeraCrystal can combine specialist scientific investigations with CMC advisory input from Dr. Matthias Gerlach. This may include development planning, regulatory CMC documentation, CDMO evaluation and technology-transfer coordination. The project scope and responsibilities are agreed for each collaboration.
ServiceCMC Strategy & Development Advisory
07 — Reach
From Cluj-Napoca to development teams across borders
TeraCrystal works from its laboratory in Cluj-Napoca with partners and scientific collaborators in Europe and beyond.
PREVIEW DATA — TO BE CONFIRMED
- LaboratoryCluj-Napoca, RomaniaHeadquarters and laboratory
- PartnershipSwitzerlandElectron diffraction partnership
- Scientific communityBologna, ItalyConvention on crystal forms
- Scientific communityBrussels, BelgiumCrystal growth of organic materials conference
- Scientific communityZagreb, CroatiaCOST Action meeting
- ClientsUnited StatesPharmaceutical and biotech teams
How a Collaboration Begins
We start by understanding the material, the unresolved scientific question, the development context and the desired output. Together we can agree the technical scope, sample and data requirements, reporting approach and project responsibilities. Confidentiality and any use of project information for public communication are addressed separately.